Objective. Coronavirus disease epidemic in 2019 (COVID-19) posed a big challenge to healthcare providers. The present study aimed explore the relationship between coronavirus anxiety and sexual function of Methods. In this study, an online survey was used providers during COVID-19 pandemic. questionnaire included Female Sexual Function Index (FSFI) Corona Disease Anxiety Scale (CDAS). Results. ...

conclusions overweight and obesity negative affect sexuality in women with sexual dysfunction. a systematic evaluation of sexual function to disclose a cause and effect relationship between obesity and fsd is suggested. objectives the purpose of this study was to investigate the association of body weight with fsd and sexual satisfaction, in ilam, western iran, in 2010 to 2011. patients and met...

Objective: To compare variables related to sexual functioning, namely: sexual desire, arousal, orgasm, pain, sexual satisfaction and sexual function in women during the pregnancy and 3 months after delivery. Methods: This is an exploratory and descriptive, quantitative study. A nonprobability, convenience sample of 62 women in the first stage, and of 52 women in the second stage, was used. The ...

background: female sexual dysfunction is a common problem among general population, especially in urogynecological patient, and can lead to a decrease in quality of life and affect martial relationship. objective: this study was compared the effect of surgical methods versus physiotherapy on sexual function in pelvic floor disorder. materials and methods: this randomized controlled trial (rct) ...

background & aim: sexual activity is one of the most important aspects of a marital life. childbirth is also a major event in the life of women, and the period of postpartum is a time of emotional upheaval. since women believe that vaginal delivery could negatively affect their sexual function after childbirth, they tend to give birth through caesarean section. therefore, this study aimed to ev...

AIM Evaluate efficacy/safety of bremelanotide (BMT), a melanocortin-receptor-4 agonist, to treat female sexual dysfunctions in premenopausal women. METHODS Patients randomized to receive placebo or BMT 0.75, 1.25 or 1.75 mg self-administered subcutaneously, as desired, over 12 weeks. Primary end point was change in satisfying sexual events/month. Secondary end points included total score chan...

Background & aim: The incidence of sexual dysfunction increases during the menopause period. Some menopause women are worried about the reduction of their marital satisfaction due to sexual dysfunction. Regarding this, the present study aimed to compare the marital satisfaction among the menopause women with and without sexual dysfunction. Methods: This cross-sectional study was conducted on 80...